ABIN741960
antibody from antibodies-online
Targeting: CXCL13
ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13
Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Immunohistochemistry [5]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN741960 - Provider product page
- Provider
- antibodies-online
- Proper citation
- Antibodies-Online Cat#ABIN741960, RRID:AB_11208849
- Product name
- anti-Chemokine (C-X-C Motif) Ligand 13 (CXCL13) (AA 50-80) antibody
- Antibody type
- Polyclonal
- Description
- Purified by Protein A.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 50-80
- Isotype
- IgG
- Vial size
- 100 μL
- Storage
- Store at -20°C
Submitted references Up-regulation of chemokine CXCL13 in systemic candidiasis.
Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study.
Orosomucoid 1 drives opportunistic infections through the polarization of monocytes to the M2b phenotype.
IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5(+) B- and T-cell trafficking to tumor-conditioned media.
Renal interstitial infiltration and tertiary lymphoid organ neogenesis in IgA nephropathy.
Li C, Cao J, Wang L, Jia X, He J, Zhang L
Clinical immunology (Orlando, Fla.) 2018 Jun;191:1-9
Clinical immunology (Orlando, Fla.) 2018 Jun;191:1-9
Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study.
Lemma SA, Pasanen AK, Haapasaari KM, Sippola A, Sormunen R, Soini Y, Jantunen E, Koivunen P, Salokorpi N, Bloigu R, Turpeenniemi-Hujanen T, Kuittinen O
European journal of haematology 2016 May;96(5):492-501
European journal of haematology 2016 May;96(5):492-501
Orosomucoid 1 drives opportunistic infections through the polarization of monocytes to the M2b phenotype.
Nakamura K, Ito I, Kobayashi M, Herndon DN, Suzuki F
Cytokine 2015 May;73(1):8-15
Cytokine 2015 May;73(1):8-15
IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5(+) B- and T-cell trafficking to tumor-conditioned media.
Pimenta EM, De S, Weiss R, Feng D, Hall K, Kilic S, Bhanot G, Ganesan S, Ran S, Barnes BJ
Immunology and cell biology 2015 May-Jun;93(5):486-99
Immunology and cell biology 2015 May-Jun;93(5):486-99
Renal interstitial infiltration and tertiary lymphoid organ neogenesis in IgA nephropathy.
Pei G, Zeng R, Han M, Liao P, Zhou X, Li Y, Zhang Y, Liu P, Zhang C, Liu X, Yao Y, Xu G
Clinical journal of the American Society of Nephrology : CJASN 2014 Feb;9(2):255-64
Clinical journal of the American Society of Nephrology : CJASN 2014 Feb;9(2):255-64
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC